Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cohn

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Circulation|December 1, 1994
Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dogK M McDonald, M Garr, P F Carlyle, et al.
American Heart Journal|January 1, 1992
A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failureS D Katz, S H Kubo, M Jessup, et al.
Circulation|August 5, 1997
Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study GroupJ N Cohn, S Ziesche, R Smith, et al.
Minnesota Medicine|April 1, 1984
Human cardiac transplantation at the University of MinnesotaJ R Schneider, D Alyono, J R Schwartz, et al.
The New England Journal of Medicine|May 3, 2001
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failureC W Yancy, M B Fowler, W S Colucci, et al.
American Journal of Hypertension|March 1, 1991
Reduced vascular compliance as a marker for essential hypertensionG E McVeigh, D E Burns, S M Finkelstein, et al.
Blood Pressure|March 1, 1993
Cardioreparation and the concept of modulating cardiovascular structure and functionK T Weber, C G Brilla, J G Cleland, et al.
American Heart Journal|August 1, 1985
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term responseK Chatterjee, W W Parmley, J N Cohn, et al.
Circulation|May 1, 1987
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrateJ N Cohn, D G Archibald, G S Francis, et al.
The New England Journal of Medicine|June 12, 1986
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative StudyJ N Cohn, D G Archibald, S Ziesche, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Circulation|December 1, 1994
Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dogK M McDonald, M Garr, P F Carlyle, et al.
American Heart Journal|January 1, 1992
A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failureS D Katz, S H Kubo, M Jessup, et al.
Circulation|August 5, 1997
Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study GroupJ N Cohn, S Ziesche, R Smith, et al.
Minnesota Medicine|April 1, 1984
Human cardiac transplantation at the University of MinnesotaJ R Schneider, D Alyono, J R Schwartz, et al.
The New England Journal of Medicine|May 3, 2001
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failureC W Yancy, M B Fowler, W S Colucci, et al.
American Journal of Hypertension|March 1, 1991
Reduced vascular compliance as a marker for essential hypertensionG E McVeigh, D E Burns, S M Finkelstein, et al.
Blood Pressure|March 1, 1993
Cardioreparation and the concept of modulating cardiovascular structure and functionK T Weber, C G Brilla, J G Cleland, et al.
American Heart Journal|August 1, 1985
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term responseK Chatterjee, W W Parmley, J N Cohn, et al.
Circulation|May 1, 1987
Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrateJ N Cohn, D G Archibald, G S Francis, et al.
The New England Journal of Medicine|June 12, 1986
Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative StudyJ N Cohn, D G Archibald, S Ziesche, et al.
Pageof 41